Attenuated vaccines for tropical theileriosis, babesiosis and heartwater: the continuing necessity

Trends in Parasitology

Volumn 23, Issue 9, 2007, Pages 420-426

  Shkap, Varda ^a   de Vos, Albertus J ^b   Zweygarth, Erich ^c   Jongejan, Frans ^d,e  

^a KIMRON VETERINARY INSTITUTE   (Israel)

^b Tick Fever Research Centre   (Australia)

^c ONDERSTEPOORT VETERINARY INSTITUTE   (South Africa)

^d Department of Infectious Diseases and Immunology   (Netherlands)

^e UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE;

BABESIOSIS; DISEASE CONTROL; EHRLICHIA RUMINANTIUM; HEARTWATER DISEASE; LIVESTOCK; NONHUMAN; PROTOZOAL INFECTION; REVIEW; THEILERIA; THEILERIA ANNULATA; THEILERIOSIS; TICK BORNE DISEASE; VACCINATION;

ANIMALS; ARACHNID VECTORS; BABESIA BOVIS; BABESIOSIS; BACTERIAL VACCINES; CATTLE; CATTLE DISEASES; EHRLICHIA RUMINANTIUM; HEARTWATER DISEASE; PROTOZOAN VACCINES; THEILERIA PARVA; THEILERIASIS; TICK-BORNE DISEASES; TICKS; VACCINES, ATTENUATED;

IXODIDA;

EID: 34547953897     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2007.07.003     Document Type: Review

References (56)

1. Jongejan F., and Uilenberg G. The Global Importance of Ticks. Parasitology 129 (2004) S3-S14
2. Kocan K., et al. Antigens and alternatives for control of Anaplasma marginale infection in cattle. Clin. Microbiol. Rev. 16 (2003) 698-712
3. Pain A., et al. Genome of the host-cell transforming parasite Theileria annulata compared with T. parva. Science 309 (2005) 131-133
4. Collins N., et al. The genome of the heartwater agent Ehrlichia ruminantium contains multiple tandem repeats of actively variable copy number. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 838-843
5. Bock R., et al. Babesiosis of cattle. Parasitology 129 (2004) S247-S269
6. Rojas C., et al. Bovine babesiosis live vaccine production. Ann. N. Y. Acad. Sci. 1081 (2006) 405-416
7. Edelhofer R., et al. Improved disease resistance after Babesia divergens vaccination. Parasitol. Res. 84 (1998) 181-187
8. Schetters T., et al. Onset and duration of immunity against Babesia canis infection in dogs vaccinated with antigens from culture supernatants. Vet. Parasitol. 138 (2006) 140-146
9. Bezuidenhout J. Cowdria vaccines. In: Wright I.G. (Ed). Veterinary Protozoan and Hemoparasite Vaccines (1989), CRC Press 31-42
10. Uilenberg G. Heartwater (Cowdria ruminantium infection): current status. Adv. Vet. Sci. Comp. Med. 27 (1983) 427-480
11. Luo J., and Lu W. Cattle theileriosis in China. Trop. Anim. Health Prod. 29 Suppl. 4 (1997) 4S-7S
12. Preston P., et al. Innate and adaptive immune responses co-operate to protect cattle against Theileria annulata. Parasitol. Today 15 (1999) 268-274
13. Shiels B. Should I stay or should I go now: a stochastic model of stage differentiation in Theileria annulata. Parasitol. Today 15 (1999) 241-245
14. Pipano E., and Shkap V. Vaccination against tropical theileriosis. Ann. N. Y. Acad. Sci. 916 (2000) 484-500
15. Uilenberg G., et al. Stage specific antigenicity in Theileria annulata: a case report. Vet. Q. 8 (1986) 73-75
16. Boulter N., and Hall R. Immunity and vaccine development in the bovine theilerioses. Adv. Parasitol. 44 (2000) 42-97
17. Gubbels M., et al. Characterization of attenuated Theileria annulata vaccines from Spain and the Sudan. Ann. N. Y. Acad. Sci. 916 (2000) 521-532
18. Shkap V., and Pipano E. Culture-derived parasites in vaccination of cattle against tick-borne diseases. Ann. N. Y. Acad. Sci. 916 (2000) 155-171
19. Singh S., et al. Field vaccination with a Theileria annulata schizont cell culture vaccine on the epidemiology of tropical theileriosis. Vet. Parasitol. 101 (2001) 91-1007
20. Gubbels M., et al. Study of Theileria annulata population structure during bovine infection and following transmission to ticks. Parasitology 123 (2001) 553-561
21. Hall R., et al. Mechanism(s) of attenuation of Theileria annulata vaccine cell lines. Trop. Med. Int. Health 4 (1999) A78-A84
22. Sommerville R., et al. Phenotypic and genomic alterations underlying the attenuation of a Theileria annulata vaccine cell line from Turkey. Vaccine 16 (1998) 569-575
23. Shkap V., et al. Proteolytic enzyme activity and attenuation of virulence in Theileria annulata schizont-infected cells. Vet. Parasitol. 115 (2003) 247-255
24. Forsyth L., et al. Bovine cells infected in vivo with Theileria annulata expresses CD11b, the C3bi complement receptor. Vet. Res. Commun. 21 (1997) 249-263
25. Glass E. The balance between protective immunity and pathogenesis in tropical theileriosis: what we need to know to design effective vaccines for the future. Res. Vet. Sci. 70 (2001) 71-75
26. Darghouth M., et al. Vaccination of calves with attenuated cell line of Theileria annulata and the sporozoite antigen SPAG-1 produces a synergistic effect. Vet. Parasitol. 142 (2006) 54-62
27. Pipano, E. et al. (2004) Theileriosis. In Manual of Standards for Diagnostic Tests and Vaccines for Terrestrial Animals, pp. 523-536, OIE (http://www.oie.int/eng/normes/mmanual/A_00059.htm)
28. Brown W., and Palmer G. Designing blood-stage vaccines against Babesia bovis and B. bigemina. Parasitol. Today 15 (1999) 275-281
29. Bock, R. et al. (2004) Bovine babesiosis. In Manual of Standards for Diagnostic Tests and Vaccines for Terrestrial Animals, pp. 507-518, OIE (http://www.oie.int/eng/normes/mmanual/A_00059.htm)
30. De Waal D., and Combrink M. Live vaccines against bovine babesiosis. Vet. Parasitol. 138 (2006) 88-96
31. Mangold A., et al. Viability after thawing and dilution of simultaneously cryopreserved vaccinal Babesia bovis and Babesia bigemina strains cultured in vitro. Vet. Parasitol. 61 (1996) 345-348
32. Hope M., et al. Potential for recombinant Babesia bovis antigens to protect against a highly virulent isolate. Parasite Immunol. 27 (2005) 439-445
33. De Vos A., et al. Protozoal and rickettsial vaccines. In: Mowat G., and Rweyemamu M. (Eds). Vaccine Manual - The Production and Quality Control of Veterinary Vaccines for Use in Developing Countries (1997), FAO 75-89
34. Timms P., et al. Study of virulence and vector transmission of Babesia bovis by use of cloned parasite lines. Infect. Immun. 58 (1990) 2171-2176
35. Bock R., and de Vos A.J. Immunity following use of Australian tick fever vaccine: a review of the evidence. Aust. Vet. J. 79 (2001) 832-839
36. Dalgliesh R., et al. Development of a highly infective Babesia bigemina vaccine of reduced virulence. Aust. Vet. J. 57 (1981) 8-11
37. Lew A., et al. Genotypic diversity in field isolates of Babesia bovis from cattle with babesiosis after vaccination. Aust. Vet. J. 75 (1997) 575-578
38. Allred D. Antigenic variation in babesiosis: is there more than one 'why'?. Microbes Infect. 3 (2001) 481-491
39. Brown W.C., et al. Immune control of Babesia bovis infection. Vet. Parasitol. 138 (2006) 75-87
40. Brown W.C., et al. Prospects for recombinant vaccines against Babesia bovis and related parasites. Parasite Immunol. 28 (2006) 315-327
41. Norimine J., et al. Stimulation of T-helper cell γ interferon and immunoglobulin G responses specific for Babesia bovis rhoptry-associated protein 1 (RAP-1) or a RAP-1 protein lacking the carboxy-terminal repeat region is insufficient to provide protective immunity against virulent B. bovis challenge. Infect. Immun. 79 (2003) 5021-5032
42. Wright I.G., et al. The development of a recombinant Babesia vaccine. Vet. Parasitol. 44 (1992) 3-13
43. Carcy B., et al. Genetic basis for GPI-anchor merozoite surface antigen polymorphism of Babesia and resulting antigenic diversity. Vet. Parasitol. 138 (2006) 33-49
44. Allred D.R., and Al-Khedery B. Antigenic variation and cytoadhesion in Babesia bovis and Plasmodium falciparum: different logics achieve the same goal. Mol. Biochem. Parasitol. 134 (2004) 27-35
45. Jongejan F. The tick-borne rickettsia Cowdria ruminantium has a Chlamydia-like life cycle. Onderstepoort J. Vet. Res. 54 (1991) 197-204
46. Mahan S., et al. Reduction of mortality from heartwater in cattle, sheep and goats exposed to field challenge using an inactivated vaccine. Vet. Parasitol. 97 (2001) 295-308
47. Jongejan F. Protective immunity to heartwater (Cowdria ruminantium infection) is acquired after vaccination with in vitro attenuated rickettsiae. Infect. Immun. 59 (1991) 729-731
48. Jongejan F., et al. Vaccination aginst heartwater using in vitro attenuated Cowdria ruminantium organisms. Rev. Elev. Med. Vet. Pays Trop. 46 (1993) 223-227
49. Gueye A., et al. Essai sur le terrain d'un vaccin atténué contre la cowdriose. Rev. Elev. Med. Vet. Pays Trop. 47 (1994) 401-404
50. Zweygarth E., and Josemans A. Continuous in vitro propagation of Cowdria ruminantium (Welgevonden stock) in a canine macrophage-monocyte cell line. Onderstepoort J. Vet. Res. 68 (2001) 155-157
51. Collins N., et al. Development of improved attenuated and nucleic acid vaccines for heartwater. Dev. Biol. (Basel) 114 (2003) 121-136
52. Zweygarth E., et al. An attenuated Ehrlichia ruminantium (Welgevonden stock) vaccine protects small ruminants against virulent heartwater challenge. Vaccine 23 (2005) 1695-1702
53. Totté P., et al. Immune responses to Cowdria ruminantium infections. Parasitol. Today 15 (1999) 286-290
54. DuPlessis J.L. Colostrum-derived antibodies to Cowdria ruminantium in the serum of calves and lambs. Onderstepoort J. Vet. Res. 51 (1984) 275-276
55. Mwangi D., et al. Immunization of cattle against heartwater by infection with Cowdria ruminantium elicits T lymphocytes that recognise major antigenic proteins 1 and 2 of the agent. Vet. Immunol. Immunopathol 85 (2002) 23-32
56. Du Plessis J.L., et al. The heterogenicity of Cowdria ruminantium stocks: cross-immunity and serology in sheep and pathogenicity in mice. Onderstepoort J. Vet. Res. 56 (1989) 195-201